Skip to main content
Premium Trial:

Request an Annual Quote

Don Enns

Microbiome Insights has appointed Don Enns as an independent member of its board of directors. Enns currently serves as VP and head of global drug delivery at Evonik Industries, joining the firm in 2016 with its acquisition of Transferra Nanoscience, where he served as president and CEO. Prior to Transferra, Enns was president and CEO at Cantest before the firm was acquired by Maxxam Analytics in 2009.

The Scan

CDC Calls Delta "Variant of Concern"

CNN reports the US Centers for Disease Control and Prevention now considers the Delta variant of SARS-CoV-2 to be a "variant of concern."

From FDA to Venture Capital

Former FDA Commissioner Stephen Hahn is taking a position at a venture capital firm, leading some ethicists to raise eyebrows, according to the Washington Post.

Consent Questions

Nature News writes that there are questions whether informed consent was obtained for some submissions to a database of Y-chromosome profiles.

Cell Studies on Multimodal Single-Cell Analysis, Coronaviruses in Bats, Urban Microbiomes

In Cell this week: approach to analyze multimodal single-cell genomic data, analysis of bat coronaviruses, and more.